All Z-Medica product development is based on independent pre-clinical and clinical research conducted by its clinical partners - renowned military and private sector medical research facilities.
The flagship product QuikClot® brand hemostatic agent was tested at the Uniformed Services University of the Health Sciences (USUHS, the military medical school) in cooperation with the Office of Naval Research, the United States Marine Corps Warfighting Laboratory and United States Marine Corps Systems Command. Both USUHS and the Navy Medical Research Center performed pre-clinical testing on QuikClot ACS™, an advanced formulation and delivery system of QuikClot®. Trauma surgeon and scientist Dr. Hasan Alam, currently with Massachusetts General Hospital and formerly with the Uniformed Services University of the Health Sciences (USUHS), was lead researcher.
Z-Medica is funding pre-clinical trials at Hartford Hospital, Hartford Connecticut to explore the use of QuikClot® in trauma surgical procedures. This research is under the direction of Lenworth M. Jacobs, M.D., MPH, FACS. Dr. Jacobs is Director of Hartford Hospital's Trauma Program, and Professor and Chairman of the Department of Traumatology and Emergency Medicine at the University of Connecticut School of Medicine.
A number of prestigious medical/clinical journals have published QuikClot® research studies and findings. |
